.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
The Evaluation of New Antiarrhythmic Drugs. Proceedings of the Symposium on How to Evaluate a New Antiarrhythmic Drug: the Evaluation of New Antiarrhythmic Agents for the Treatment of Ventricular Arrhythmias, Held at Philadelphia, Pennsylvania, October 8
. Ed(S): Morganroth, Joel; Moore, E. Neil; Dreifus, Leonard S.; Michelson, E.L.
€ 67.40
FREE Delivery in Ireland
Description for The Evaluation of New Antiarrhythmic Drugs. Proceedings of the Symposium on How to Evaluate a New Antiarrhythmic Drug: the Evaluation of New Antiarrhythmic Agents for the Treatment of Ventricular Arrhythmias, Held at Philadelphia, Pennsylvania, October 8
Paperback. Proceedings of the First Symposium on New Drugs and Devices, held in Philadelphia, PA, USA (1980) Editor(s): Morganroth, Joel; Moore, E. Neil; Dreifus, Leonard S.; Michelson, E.L. Series: Developments in Cardiovascular Medicine. Num Pages: 340 pages, biography. BIC Classification: MJD. Category: (P) Professional & Vocational. Dimension: 234 x 156 x 18. Weight in Grams: 522.
Thus, there are now several chronic canine myocardial infarction ventricular tachyarrhythmia models which are available for the evaluation of new antiarrhythmic drugs (Table I). The available models fulfill many, but not all of the requirements for an ideal chronic arrhythmia model (Table 11). The sustained arrhythmias initiated in these models using programmed pacing presumably have the same localized reentrant mechanism that characterizes chronic human myocardial infarction and chronic coronary 26 artery disease. However, these models are not suitable for determining whether a new drug will abolish spontaneous ly-occurring PVCs. In addition, these models are of unproven value in the study ... Read more
Thus, there are now several chronic canine myocardial infarction ventricular tachyarrhythmia models which are available for the evaluation of new antiarrhythmic drugs (Table I). The available models fulfill many, but not all of the requirements for an ideal chronic arrhythmia model (Table 11). The sustained arrhythmias initiated in these models using programmed pacing presumably have the same localized reentrant mechanism that characterizes chronic human myocardial infarction and chronic coronary 26 artery disease. However, these models are not suitable for determining whether a new drug will abolish spontaneous ly-occurring PVCs. In addition, these models are of unproven value in the study ... Read more
Product Details
Format
Paperback
Publication date
2011
Publisher
Springer Netherlands
Number of pages
340
Condition
New
Series
Developments in Cardiovascular Medicine
Number of Pages
340
Place of Publication
Dordrecht, Netherlands
ISBN
9789400982727
SKU
V9789400982727
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for The Evaluation of New Antiarrhythmic Drugs. Proceedings of the Symposium on How to Evaluate a New Antiarrhythmic Drug: the Evaluation of New Antiarrhythmic Agents for the Treatment of Ventricular Arrhythmias, Held at Philadelphia, Pennsylvania, October 8